Inovio Pharmaceuticals Inc
NASDAQ:INO 9:46:08 AM EDT
| Market Cap (Intraday) | 242.13M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $11.04 |
| 50-Day MA | $10.04 |
| 200-Day MA | $6.71 |
Inovio Pharmaceuticals Inc Stock, NASDAQ:INO
660 West Germantown Pike, Suite 110, Plymouth Meeting, Pennsylvania 19462-1111
United States of America
Phone: +1.267.440.4200
Number of Employees: 122
Description
Inovio Pharmaceuticals, Inc. engages in the provision of designed DNA medicines to treat and protect people from infectious diseases, cancer, and diseases associated with human papillomavirus. Its product pipeline includes VGX-3100, INO-3107, INO-5410, INO-4800, and PENNVAX-GP. The company was founded by David B. Weiner on June 29, 1983 and is headquartered in Plymouth Meeting, PA.